May 8, 2018 / 10:44 PM / in 2 months

BRIEF-Bellicum Pharmaceuticals Reports Q1 Loss Per Share Of $0.68

May 8 (Reuters) - Bellicum Pharmaceuticals Inc:

* BELLICUM PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS $0.68

* Q1 EARNINGS PER SHARE VIEW $-0.69 -- THOMSON REUTERS I/B/E/S

* QTRLY GRANT REVENUE $154,000 VERSUS $128,000

* Q1 REVENUE VIEW $32860.00 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below